AXIM Biotechnologies, Inc.
AXIM
$0.003
$0.000.00%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.14M | -5.59M | -8.06M | -7.06M | -9.42M |
| Total Depreciation and Amortization | 429.70K | 428.40K | 427.20K | 427.20K | 427.10K |
| Total Amortization of Deferred Charges | 220.50K | 201.40K | 219.30K | 238.30K | 255.80K |
| Total Other Non-Cash Items | 1.42M | 3.18M | 5.09M | 3.90M | 6.01M |
| Change in Net Operating Assets | 1.30M | -170.90K | 1.29M | 1.13M | 1.31M |
| Cash from Operations | -759.00K | -1.96M | -1.03M | -1.37M | -1.42M |
| Capital Expenditure | -2.80K | -2.80K | -- | 0.00 | -2.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2.80K | -2.80K | -- | 0.00 | -2.70K |
| Total Debt Issued | 300.00K | 775.00K | 675.00K | 575.00K | 527.30K |
| Total Debt Repaid | 0.00 | 0.00 | -26.80K | -62.60K | -113.50K |
| Issuance of Common Stock | 1.11M | 1.23M | 491.50K | 712.60K | 1.04M |
| Repurchase of Common Stock | -743.70K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 670.40K | 2.00M | 1.14M | 1.23M | 1.46M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -91.50K | 43.20K | 109.20K | -140.50K | 32.40K |
